Villanueva, Jerum Jr. A.

HRN: 23-70-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/17/2023
09/23/2023
IV
160mg
TID
Typhlitis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  BloodstreamIntra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: